Vantage Consulting Group Inc Viatris Inc Transaction History

Vantage Consulting Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.05 - $12.02 $35,476 - $42,430	3,530 Added 18.21%	22,913 $243,000
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $49,959 - $59,978	-4,433 Reduced 18.61%	19,383 $231,000
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $7,770 - $9,613	886 Added 3.86%	23,816 $257,000
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $16,005 - $18,943	-1,669 Reduced 6.78%	22,930 $226,000
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $5,565 - $6,348	617 Added 2.57%	24,599 $245,000
Q1 2023 May 10, 2023	BUY	$9.2 - $12.26 $14,177 - $18,892	1,541 Added 6.87%	23,982 $230,000
Q4 2022 Feb 13, 2023	SELL	$8.72 - $11.56 $31,051 - $41,165	-3,561 Reduced 13.7%	22,441 $249,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $38,541 - $50,585	4,545 Added 21.18%	26,002 $222,000
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $14,437 - $17,803	-1,451 Reduced 6.33%	21,457 $225,000
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $23,975 - $37,637	2,444 Added 11.94%	22,908 $249,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $34,746 - $42,190	2,874 Added 16.34%	20,464 $277,000
Q3 2021 Nov 10, 2021	BUY	$13.25 - $15.13 $42,135 - $48,113	3,180 Added 22.07%	17,590 $238,000
Q2 2021 Aug 11, 2021	BUY	$12.97 - $16.15 $34,059 - $42,409	2,626 Added 22.28%	14,410 $206,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $22,831 - $31,147	-1,680 Reduced 12.48%	11,784 $165,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $192,535 - $252,315	13,464 New	13,464 $252,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.